UNSPSC 51451701: Bephenium

This classification denotes an antinematodal agent with the molecular formula C17H22NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PXO9B4983I, chemically known as n,n-dimethyl-n-(2-phenoxyethyl)-benzenemethanaminium but generally known as bephenium, which bears US NIH Compound Identifier 19667. Bephenium most often comes in chloride and hydroxynaphthoate forms. World Health Organization schedules bephenium in its Anatomical Therapeutic Chemical (ATC) Classification.

As of Q4 2014, BEPHENIUM remains the US FDA Preferred Term for this commodity. SMILES: C[N+](C)(CCOC1=CC=CC=C1)CC2=CC=CC=C2.

UNSPSC 51451701 Bephenium is a Commodity code that does not map meaningfully to the recent state and local solicitations tagged under it. The source shows no active procurement opportunities for bephenium—an anthelmintic pharmaceutical—under this code. Instead, the four most recent state and local opportunities tagged under UNSPSC 51451701 concern naloxone and drug deactivation systems, direct-to-manufacturer pharmacy programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals distributed through wholesaler networks. None of these solicitations address bephenium or its clinical applications. The mismatch suggests either a tagging error in the state and local procurement databases or that bephenium procurement activity has moved to a different UNSPSC classification.

The code shows no relevant recent activity for business development professionals evaluating actual demand under the bephenium commodity line. Firms pursuing state and local pharmaceutical contracts should verify UNSPSC mapping in procurement portals before assuming this code reflects active opportunities in their target markets.